Discover some video interviews with some distinguished international speakers at ILCA 2016

Prof. Richard Finn on Finding a Biomarker for Patients With HCC

Dr. Anthony El-Khoueiry on the Rationale for Evaluating Nivolumab in Advanced HCC

Prof. Morris Sherman on Screening Obstacles in Liver Cancer

Dr. Klaus Hoeflich on Treatment Challenges With Liver Cancer


Dr. Francis Yao on the Milan Criteria in Liver Cancer


Dr. Ju Dong Yang on NASH-Associated HCC and Cirrhosis in Diagnosis of Liver Cancer

Dr. Richard Kinh Gian Do on the Assessment of Tumor Response in Liver Cancer

Dr. Andrew X. Zhu on Optimal Second-Line Treatment for Patients With HCC